Table 1 Participant characteristics, HIV-1 infecting clade, Fiebig stage and HLA class I haplotypes
Subject | Sex | Age range (years) | HIV-1 subtype | Class-I HLA | Early Time Point (Days) | Fiebig Staging | Late Time Point (Days) |
|---|---|---|---|---|---|---|---|
91 | M | 31–40 | A | A*0201,*0301;B*5301,*5802;Cw*0401,*0602 | 121 | VI | 841 |
92 | F | 21–30 | D | A*0201,*3002;B*4403,*1402Cw*0401,*0802 | 52 | VI | 743 |
94 | M | 51–60 | A | A*3402,*7401;B*4403,*5802;Cw*0401,*0602 | 28 | V | 358 |
95 | M | 21–30 | A | A*2301,*7401;B*4403,*1510;Cw*0401,*1601 | 30 | VI | 570 |
913 | F | 11–20 | D | A*0201,*3402;B*4501,*4701;Cw*0602,*1601 | 61 | VI | 211 |
914 | F | 21–30 | D | A*0101,*0201;B*0702,*4415;Cw*0407,*0702 | 31 | IV | 181 |